RHOADS ANN D 4

What Happened
Ann D. Rhoads, a director of QuidelOrtho Corporation (QDEL), was granted three restricted stock unit (RSU) awards on June 25, 2026 totaling 19,599 RSUs (15,532; 3,698; and 369). Each RSU represents the right to receive one share of common stock; the awards were granted at $0.00 per share (no cash purchase) and are derivative awards that convert to shares upon vesting.

Key Details

• Transaction date: June 25, 2026; filing date: June 29, 2026 (Form 4) — appears timely (Form 4 is due within 2 business days).
• Grants: 15,532 RSUs, 3,698 RSUs, and 369 RSUs; grant price reported as $0.00 (award). Total granted = 19,599 RSUs.
• Vesting / release notes from the filing:
  • F1: Each RSU = right to one share.
  • F2: Some RSUs will vest on June 25, 2027.
  • F3: These RSUs were received in lieu of cash director retainer fees under a deferred compensation program; release of vested RSUs will follow the director’s elected deferral schedule.
  • F4: The 3,698-RSU block vests in four tranches: 924 shares on 6/25/2026, 924 on 9/25/2026, 925 on 12/25/2026, and 925 on 3/25/2027.
• Shares owned after the transaction: not disclosed in the filing.

Context
RSU awards are compensation-based, not open-market purchases or sales; they don’t necessarily signal immediate trading intent. Because these were issued in lieu of cash retainers and follow a deferral/vesting schedule, the economic benefit to the director depends on future vesting and any elected deferral dates. For retail investors, awards are informative about executive/director pay and potential future share issuance but should not be read as a direct buy/sell endorsement.